- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05635682
Investigation of the Relationship Between Different Assesments in Individuals in Opioid Maintenance Treatment Process
Investigation of the Relationship Between Sensation, Balance, Gait, Posture and Reaction Time in Individuals in Opioid Maintenance Treatment Process
Opioid use disorder is the chronic use of opioids that causes clinically significant distress or impairment. More than 16 million people world wide are opioid addicts. The diagnosis of opioid use disorder is based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Despite the social and personal consequences of opioid use disorder in individuals; It consists of an excessive desire to use opioids, increased opioid tolerance, and withdrawal syndrome when discontinued. Examples of opioids include heroin, morphine, codeine, synthetic opioids such as fentanyl and oxycodone.
In many countries, the main pharmacological approach in the treatment of opioid use disorder is maintenance therapy using opioid agonists. The combination of buprenorphine and naloxone is one of the most effective agents used in maintenance therapy. Due to the effects of both opioid use and maintenance therapy, these individuals have sensory problems, balance and gait disturbances, and a prolonged reaction time.
The aim of this study is to examine the relationship between sensation, balance, gait, posture and reaction time in individuals on opioid maintenance therapy and to compare them with healthy individuals.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be conducted with the participation of 80 people between the ages of 18 and 65, including 40 individuals who have voluntarily agreed to participate in the study, who have received opioid use disorder according to the DSM V diagnostic criteria and are in the process of maintenance treatment, and 40 healthy individuals. Dec.
Within the scope of the study, the cognitive levels of the participants will be evaluated by Montreal Cognitive Assessment (MoCA).
Sensory evaluations will be made in the form of proprioception sense, light touch sense, vibration sense and two-point discrimination assessment. Proprioception assessments will be performed using a digital inclinometer for the neck and torso separately (J-Tech Dualer IQ, J-Tech Medical Industries, Salt Lake City, USA).
The posture assessment will be performed by the New York Posture Analysis Method.
The Semmes Weinstein Monofilament Test (SWMT) will be used to assess the sense of touch and pressure on the sole of the foot.The test will be applied to the first metatarsal head, medial foot, lateral foot and heel. 3 Repetitions will be performed for each zone. At the end of the test, the values of the four regions will be added and divided into four and the average value will be calculated. The right and left extremities will be evaluated separately.
A 128 Hz diaposon will be used to assess the sense of vibration. The test will be applied to the first metatarsal head, medial foot, lateral foot and heel. The right and left extremities will be evaluated separately.
Discriminator (Baseline ® Discrimin-A-Gon 2) for the assessment of the sense of two-point separation- Point Discriminator, New York, USA) will be used. The test will be applied to the first metatarsal head, medial foot, lateral foot and heel.The right and left extremities will be evaluated separately.
For balance and walking; Tinetti Balance and Walking Test will be applied. Reaction time will be assessed by the Nelson foot test. By taking five measurements, the best and worst values will be discarded, and the average of the remaining three measurements will be recorded as the distance at which the ruler fell.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey (Türkiye), 06490
- Gazi University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- To be male and between the ages of 18-65,
- For the study group, diagnosed with opioid use disorder according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders V (DSM V) and being on maintenance treatment,
- To voluntarily agree to participate in the study,
Exclusion Criteria:
- Having any systemic or neurological disease,
- To have a cognitive effect at a level that will affect communication,
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study Group
Individuals in the process of maintenance therapy with opioid use disorder
|
Plantar sensation, foot reaction time, head and trunk proprioceptions, posture, balance and gait assesments
|
|
Control Group
Healty people
|
Plantar sensation, foot reaction time, head and trunk proprioceptions, posture, balance and gait assesments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plantar sensation -Tactile sense-
Time Frame: 1. Day
|
Tactile sense was assessed using a full Semmes-Weinstein Monofilament test kit (North Coast Medical, San Jose, CA, USA).
The smallest (1.65) monofilament was used firstly.
The trial test was performed once before the assessment with eyes open and closed to introduce the test to each child.
The monofilament was held perpendicular to the skin and pressed into the skin until it was slightly dished and held for 1.5 s in the pressed region and 1.5 s in the air.
The child was asked to indicate if he/she felt the touch.
|
1. Day
|
|
Plantar sensation - Vibration sense-
Time Frame: 1. Day
|
A 128 Hz tuning fork (Baseline® Tuning Fork, New York, USA) was used to assess the vibration sense.
The duration of the vibration was measured by a chronometer, started when the fork touched to the child's skin and stopped when the child indicated that "it has finished".
|
1. Day
|
|
Plantar sensation - Two-point discrimination sense-
Time Frame: 1. Day
|
A discriminator (Baseline®Discrim-A-Gon 2-Point Discriminator, New York, USA) was used for the assessment of the two-point discrimination sense.
The assessment was started at the maximum distance and gradually decreased until the child was not able to differentiate the two points.
When the subject felt the two points as one in two of the three trials, the distance was noted in mm.
Light pressure was applied simultaneously at both ends of the discriminator to apply as equal pressure as possible.
|
1. Day
|
|
Reaction time - Foot reaction time-
Time Frame: 1. Day
|
Reaction time was evaluated with Nelson's foot test.
For the test, the subject sits against the wall with the toe tip 2.5 cm and the heel part 5 cm.
The test administrator will hold the reaction ruler between the wall and the subject's foot, and when the subject is ready, he will release the ruler and the subject holds the fallen ruler by squeezing it against the wall with his foot.
Five measurements were taken and the best and worst values were discarded, and the average of the remaining three measurements was recorded as the distance the ruler fell.
|
1. Day
|
|
Proprioception-Neck proprioception
Time Frame: 1. Day
|
For neck prorioception; One end of the dual digital inclinometer is placed at the level of the 7th cervical vertebra and the other end is placed on the apex of the participant's head.
The person is asked to close their eyes.
After the neck is brought to the reference angle, it is ensured that the person perceives the angle by waiting for 10 seconds.
Then, the person is asked to bring his head to an upright position and then repeat the taught reference angle as he perceives it.
The absolute value of the angle at which it deviates from the target is recorded.
In our study, 30° neck flexion will be accepted as the target angle value and the average of the evaluations was taken by making 3 evaluations.
|
1. Day
|
|
Proprioception-Trunk proprioception
Time Frame: 1. Day
|
For trunk proprioception, in the standing position, the first part of the inclinometer is fixed on the S1 spinous process, which is located and marked by palpation, and the second part is fixed on the T1 spinous process, which is also determined and marked by palpation, and the eyes of the person are closed.
After the body is brought to the reference angle, it is ensured that the person perceives the angle by waiting for 10 seconds.
Then, the person is asked to bring his/her torso to an upright position and then repeat the taught reference angle as he/she perceives it.
The absolute value of the angle at which it deviates from the target is recorded.
In our study, 30° trunk flexion will be accepted as the target angle value, and 3 evaluations were made and the average of the evaluations was taken.
|
1. Day
|
|
Posture
Time Frame: 1. Day
|
Posture assessment was done with the New York Posture Analysis (NYPA).
The NYPA is a quantitative scale that evaluates whether the alignment of various body segments is appropriate for an individual in an anatomical position.
NYPA has a form in which the body is examined in thirteen separate sections, and the posture assessment is scored using the visuals in these sections.
|
1. Day
|
|
Balance and Gait-Tinetti Balance And Gait Test
Time Frame: 1. Day
|
For balance and walking; Tinetti Balance and Gait Test was applied.
The balance test includes sitting balance, standing and standing balance, evaluation of balance with eyes open and closed, 360 degree rotation around itself and evaluation of reaching.
In the walking test, initiation of walking, step height, step width, step symmetry, step continuity, deviation from the walking line and trunk stability are evaluated.
The questions are scored between 0-2, with a maximum of 26 points for balance and a maximum of 9 points for walking, with a total maximum score of 35.
A total score of 18 or less indicates a high risk of falling, a score of 19-24 indicates a moderate fall risk, and a score of 24 and above indicates a low risk of falling.
|
1. Day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 66442466-604.01.02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid Use Disorder
-
Wake Forest University Health SciencesUniversity of Chicago; Rogers Behavioral Health; University of California Santa...RecruitingSubstance Use | Methamphetamine-dependence | Opioid Use | Opioid-use Disorder | Cocaine Use Disorder | Cocaine Use | Methamphetamine AbuseUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)CompletedSubstance Use Disorder | Opioid Use Disorder | Heroin Use DisorderUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Vanderbilt University Medical CenterCompletedOpioid Use | Opioid-use DisorderUnited States
-
Center for Progressive Recovery, LLCNational Institute on Drug Abuse (NIDA); Yale UniversityCompletedCriminal Behavior | Opioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Albert Einstein College of MedicineNational Institute on Drug Abuse (NIDA); Pfizer; National Institutes of Health...CompletedTobacco Use Disorder | Opioid-use DisorderUnited States
-
Indivior Inc.CompletedOpioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Brigham and Women's HospitalOhio State UniversityActive, not recruitingOpioid Dependence | Opioid Use | Opioid-use DisorderUnited States
-
Indiana UniversityCompletedOpioid Use | Opioid-use DisorderUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Columbia University; Weill Medical College... and other collaboratorsEnrolling by invitationOpioid Use | Opioid Court Model | Medication to Treat Opioid Use DisorderUnited States
Clinical Trials on Observational and anthropometric assesments
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingNutrition Assessment
-
University of GaziantepNot yet recruitingCardiovascular Diseases | Metabolic Syndrome | Chronic Kidney Disease(CKD)Turkey
-
University of CatanzaroRecruitingVascular Diseases | Psychosocial Problem | Social FunctioningItaly
-
Yuksek Ihtisas UniversityCompleted
-
Istituto Auxologico ItalianoRecruiting
-
University Hospital TuebingenActive, not recruitingDiabetes Mellitus, Type 2 | Insulin Resistance | OsteoporosisGermany
-
Hasanuddin UniversityRecruitingVitamin D DeficiencyIndonesia
-
Universidade do PortoCentro Hospitalar Universitário de São João, E.P.E.; Centro de Investigação... and other collaboratorsRecruitingNutritional Status | Diet, Vegetarian | Diet, Vegan | Metabolic ProfilePortugal